Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 20, 2024
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservationBeryl L Manning-Geist, Eric Rios-Doria, Ying L Liu, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Gynecologic Oncology|July 8, 2022
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysisKaren Cadoo, Fiona Simpkins, Cara Mathews, et al.
Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.
Cancer|August 16, 2024
Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancerMackenzie W Sullivan, Stephen Graves, Anusha Adkoli, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2020
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancerYing L Liu, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|December 8, 2024
Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancerStephen Graves, Mackenzie W Sullivan, Anusha Adkoli, et al.
Gynecologic Oncology|June 28, 2024
Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilitiesBeryl L Manning-Geist, Mackenzie W Sullivan, Qin Zhou, et al.
Pageof 21